PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies-Reference-Cited by-同舟云学术

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies

Published:2016-09-22 Issue:3 Volume:31 Page:697-704
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Qazilbash M H,Wieder E,Thall P F,Wang X,Rios R,Lu S,Kanodia S,Ruisaard K E,Giralt S A,Estey E H,Cortes J,Komanduri K V,Clise-Dwyer K,Alatrash G,Ma Q,Champlin R E,Molldrem J J

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/leu2016254.pdf

Reference34 articles.

1. Molldrem J, Dermime S, Parker K, Jiang YZ, Mavroudis D, Hensel N et al. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 1996; 88: 2450–2457.

2. Molldrem JJ . Vaccination for leukemia. Biol Blood Marrow Transplant 2006; 12 (Suppl 1): 13–18.

3. Molldrem JJ, Clave E, Jiang YZ, Mavroudis D, Raptis A, Hensel N et al. Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units. Blood 1997; 90: 2529–2534.

4. Molldrem JJ, Lee PP, Wang C, Felio K, Kantarjian HM, Champlin RE et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 2000; 6: 1018–1023.

5. Molldrem JJ, Lee PP, Kant S, Wieder E, Jiang W, Lu S et al. Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. J Clin Invest 2003; 111: 639–647.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo;Cytotherapy;2024-07

2. Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer;Cancer Research Communications;2024-02-22

3. Hu8F4-CAR T cells with mutated Fc spacer segment improve target-specificity and mediate anti-leukemia activity in vivo;2024-02-19

4. Vaccines: a promising therapy for myelodysplastic syndrome;Journal of Hematology & Oncology;2024-01-08

5. Modulating the immune system as a therapeutic target for myelodysplastic syndromes and acute myeloid leukemia;Biochemistry and Cell Biology;2023-12-01